Literature DB >> 9639374

Apoptosis and related proteins in different stages of human atherosclerotic plaques.

M M Kockx1, G R De Meyer, J Muhring, W Jacob, H Bult, A G Herman.   

Abstract

BACKGROUND: The transition of a fatty streak into an atherosclerotic plaque is characterized by the appearance of focal and diffuse regions of cell death. We have investigated the distribution of apoptotic cell death and apoptosis-related proteins in early and advanced atherosclerotic lesions. METHODS AND
RESULTS: Human atherosclerotic plaques were studied by whole-mount carotid endarterectomy specimens (n=18). This approach allowed comparison of adaptive intimal thickenings, fatty streaks, and advanced atherosclerotic plaques of the same patient. The fatty streaks differed from adaptive intimal thickenings by the presence of BAX (P<0.01), a proapoptotic protein of the BCL-2 family. Both regions were composed mainly of smooth muscle cells (SMCs), and macrophage infiltration was low and not different. Apoptosis, as detected by DNA in situ end labeling (terminal deoxynucleotidyl transferase end labeling [TUNEL] and in situ nick translation) was not present in these regions. Apoptosis of SMCs and macrophages, however, was present in advanced atherosclerotic plaques that were present mainly in the carotid sinus. A dense infiltration of macrophages (5.8+/-3% surface area) was present in these advanced atherosclerotic plaques. Cytoplasmic remnants of apoptotic SMCs, enclosed by a cage of thickened basal lamina, were TUNEL negative and remained present in the plaques as matrix vesicles.
CONCLUSIONS: We conclude that SMCs within human fatty streaks express BAX, which increases the susceptibility of these cells to undergo apoptosis. The localization of these susceptible SMCs in the deep layer of the fatty streaks could be important in our understanding of the transition of fatty streaks into atherosclerotic plaques, which are characterized by regions of cell death. Matrix vesicles are BAX-immunoreactive cytoplasmic remnants of fragmented SMCs that can calcify and may be considered the graves of SMCs that have died in the plaques.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9639374     DOI: 10.1161/01.cir.97.23.2307

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  86 in total

Review 1.  Vascular smooth muscle cell apoptosis in atherosclerosis.

Authors:  J J Boyle
Journal:  Int J Exp Pathol       Date:  1999-08       Impact factor: 1.925

Review 2.  The role of phosphorus in the development and progression of vascular calcification.

Authors:  Jessica Kendrick; Michel Chonchol
Journal:  Am J Kidney Dis       Date:  2011-09-28       Impact factor: 8.860

Review 3.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 4.  Pathological changes in the coronary arteries in the acute coronary syndromes.

Authors:  M M Kockx; M W Knaapen
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

5.  Genetic polymorphisms of TP53 and FAS promoter modulate the progression of coronary artery disease after coronary artery bypass grafting: a gender-specific view.

Authors:  A Beiras-Fernandez; M K Angele; C Koutang; P Lohse; B Reichart; P Lohse; S Eifert
Journal:  Inflamm Res       Date:  2011-02-01       Impact factor: 4.575

6.  Microparticles of human atherosclerotic plaques enhance the shedding of the tumor necrosis factor-alpha converting enzyme/ADAM17 substrates, tumor necrosis factor and tumor necrosis factor receptor-1.

Authors:  Matthias Canault; Aurélie S Leroyer; Franck Peiretti; Guy Lesèche; Alain Tedgui; Bernadette Bonardo; Marie-Christine Alessi; Chantal M Boulanger; Gilles Nalbone
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

Review 7.  Has our understanding of calcification in human coronary atherosclerosis progressed?

Authors:  Fumiyuki Otsuka; Kenichi Sakakura; Kazuyuki Yahagi; Michael Joner; Renu Virmani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-20       Impact factor: 8.311

Review 8.  Mechanisms and consequences of macrophage apoptosis in atherosclerosis.

Authors:  Tracie Seimon; Ira Tabas
Journal:  J Lipid Res       Date:  2008-10-25       Impact factor: 5.922

9.  The Relationship of Serum Soluble Fas Ligand (sFasL) Level with the Extent of Coronary Artery Disease.

Authors:  Asife Sahinarslan; Bulent Boyaci; Sinan Altan Kocaman; Salih Topal; Ugur Ercin; Kaan Okyay; Neslihan Bukan; Ridvan Yalçin; Atiye Cengel
Journal:  Int J Angiol       Date:  2012-03

Review 10.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.